Charles River Laboratories
CRL · NYSE
Bulios Fair Price
$209.88
27.4% downside
Aktualna cena
$289.09
Według Bulios Fair Price akcje CRL są obecnie przewartościowane względem ich ceny rynkowej. Jak to działa?
Bulios Fair Price to szacunkowa godziwa wartość akcji z modelu wyceny Bulios. To materiał do Twojej własnej analizy, a nie rekomendacja inwestycyjna. Jak to działa?
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
O spółce
Charles River Laboratories International, Inc. (CRL) is an American company operating in the biotechnology and pharmaceutical research industry. The company specializes in providing preclinical and clinical services to pharmaceutical and biotechnology companies, academic institutions, and government organizations. Its services include drug testing, toxicity studies, pharmacokinetics, viral safety testing, genetic analysis, and other biological and chemical analyses. Charles River Laboratories has a broad portfolio of laboratory and clinical services that are crucial for the development of new drugs and treatment protocols. The company emphasizes quality, innovation, and ethical standards in its research and laboratory practices. It is recognized as a significant partner for the pharmaceutical and biotechnology sectors. Charles River Laboratories International, Inc. (CRL) shares are publicly traded on the stock exchange and may represent an attractive investment opportunity for investors monitoring the biotechnology and pharmaceutical industry and seeking investments in a company with a significant position in drug research and development.
Opis nie jest jeszcze dostępny w Twoim języku, więc tekst jest po angielsku.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Birgit Girshick
Employees
19,000
Headquarters
Wilmington
Nadchodzące wydarzenia
Earnings
Upcoming earnings report